BioPharma Credit
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. BioPharma Credit's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 26% to $135,737,000. The net income dropped to $108,450,000 and profit margin reached 80%. Total operating expenses were $2,037,000.
Profit Margin
| 2017 | 33.64M | 27.16M | 80.73% |
|---|---|---|---|
| 2018 | 78.72M | 70.14M | 89.11% |
| 2019 | 124.11M | 122.32M | 98.56% |
| 2020 | 91.35M | 89.13M | 97.57% |
| 2021 | 87.96M | 84.95M | 96.58% |
| 2022 | 184.24M | 182.31M | 98.95% |
| 2023 | 135.73M | 108.45M | 79.9% |
BPCR.L Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 135.73M | 184.24M | 87.96M | 91.35M | 124.11M | 78.72M | 33.64M |
Cost of revenue | 50.49M | 0 | 0 | 18.65M | 0 | 0 | 0 |
Gross profit | 85.24M | 184.24M | 87.96M | 72.69M | 124.11M | 78.72M | 33.64M |
Operating exp. | |||||||
Research and development | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling and marketing | 175K | 200K | 200K | 202K | 204K | 245K | 0 |
Total operating expenses | 2.03M | 1.93M | 3.01M | 2.21M | 1.79M | 8.57M | 6.48M |
Operating income | 108.45M | 182.31M | 84.95M | 89.13M | 122.32M | 70.14M | 27.12M |
Other income (expenses), net | 0 | -29K | -18K | 0 | -12K | -3K | 40.28K |
Income before tax | 108.45M | 182.31M | 84.95M | 89.13M | 122.32M | 70.14M | 27.16M |
Income tax expense | 0 | 182.31M | 84.95M | 89.13M | 122.32M | 0 | 40.28K |
Net income | 108.45M | 182.31M | 84.95M | 89.13M | 122.32M | 70.14M | 27.16M |
Earnings per share | |||||||
Basic EPS | 0.08 | 0.13 | 0.06 | 0.06 | 0.08 | 0.07 | 0.03 |
Diluted EPS | 0.08 | 0.13 | 0.06 | 0.06 | 0.08 | 0.07 | 0.03 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |